Last 155.30 INR
Change Today +3.60 / 2.37%
Volume 67.6K
JOL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

jubilant life sciences ltd (JOL) Snapshot

Open
152.00
Previous Close
151.70
Day High
156.05
Day Low
152.00
52 Week High
06/13/14 - 222.00
52 Week Low
10/23/13 - 78.35
Market Cap
24.7B
Average Volume 10 Days
97.6K
EPS TTM
6.85
Shares Outstanding
159.3M
EX-Date
08/21/14
P/E TM
22.7x
Dividend
3.00
Dividend Yield
1.93%
Current Stock Chart for JUBILANT LIFE SCIENCES LTD (JOL)

Related News

No related news articles were found.

jubilant life sciences ltd (JOL) Related Businessweek News

No Related Businessweek News Found

jubilant life sciences ltd (JOL) Details

Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company, manufactures and supplies pharmaceutical and life sciences products and services worldwide. The company provides active pharmaceutical ingredients (APIs) for cardiovascular system (CVS) and central nervous system (CNS), as well as anti-infective and anti-ulcerants. Its APIs include solid dosage formulations for CVS, CNS, and anti-allergy categories; radiopharmaceuticals for the diagnosis, treatment, and monitoring of diseases; and allergy therapy products, including allergenic extracts and mixes, and skin test devices. The company also offers life sciences ingredients, such as pyridine and picoline; fine chemicals; crop science chemicals; nutrition products, including niacinamide, niacin (vitamin B3), and choline chloride; animal nutrition products in the category of vitamin and mineral premixes, betaine, acidifiers, toxin binders, growth promoters, and emulsifiers; acetyl products, which include acetic acid, monochloro acetic acid, acetic anhydride, ethyl acetate, and sodium mono chlor acetate; and specialty gases, such as liquid carbon dioxide and ethylene oxide mixtures. In addition, it provides contract manufacturing services in manufacturing sterile injectables, and solid and semi solid dosage forms; drug discovery services in bioinformatics, chemoinformatics, and crystallography structure directed molecular design and information technology; pre clinical services, such as medicinal chemistry, analytical chemistry, custom synthesis, library design, and clinical development and market launch services; and conducts integrated drug discovery and development programs on oncology, metabolic disorders, pain, and inflammation. The company was formerly known as Jubilant Organosys Limited and changed its name to Jubilant Life Sciences Limited in 2010. Jubilant Life Sciences Limited was incorporated in 1978 and is based in Noida, India.

6,200 Employees
Last Reported Date: 08/5/14
Founded in 1978

jubilant life sciences ltd (JOL) Top Compensated Officers

Vice President of Legal
Total Annual Compensation: --
Compensation as of Fiscal Year 2012.

jubilant life sciences ltd (JOL) Key Developments

BioResource Enters into Marketing Agreement with Jubilant Life Sciences

BioResource International, Inc. has entered into a marketing agreement with Jubilant Life Sciences to market and distribute selected feed enzyme products in South Asia. Jubilant will be the exclusive marketing partner of BRI's Xylamax and XylaQuick products in South Asia. Jubilant will market and distribute Xylamax and XylaQuickto large volume poultry producers, feed integrators, and animal health and nutrition consultants throughout India, Pakistan, Sri Lanka, Nepal, Bangladesh and Bhutan. The unique XylaQuick (Xylamax Qualitative In-feed Colorimetric Kit) testallows for easy, on-site testing to confirm that Xylamax has been added and properly distributed within theanimal feed.

Jubilant Life Sciences Limited Announces Resignation of Directors

Jubilant Life Sciences Ltd. announced that Dr. Inder Mohan Verma and Mr. Suresh Kumar have resigned as Directors from the Board of the company.

Jubilant Life Sciences Ltd Appoints Dr. Ashok Misra as Additional Director

Jubilant Life Sciences Ltd. announced that Dr. Ashok Misra has been appointed as Additional Director of the company, in the category of Independent Director, with effect from September 15, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JOL:IN 155.30 INR +3.60

JOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dishman Pharmaceuticals & Chemicals Ltd 153.70 INR +1.35
Glenmark Pharmaceuticals Ltd 704.20 INR -1.65
Piramal Enterprises Ltd 684.55 INR -5.05
Shasun Pharmaceuticals Ltd 202.10 INR +0.10
Torrent Pharmaceuticals Ltd 850.30 INR +21.65
View Industry Companies
 

Industry Analysis

JOL

Industry Average

Valuation JOL Industry Range
Price/Earnings 14.2x
Price/Sales 0.4x
Price/Book 0.9x
Price/Cash Flow 5.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JUBILANT LIFE SCIENCES LTD, please visit www.jubl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.